CUBE vs TRDA
CubeSmart (CUBE) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the CUBE and TRDA stock pages for the full models.
Not investment advice.